Cancer :: Tablet is better all round for cancer patients

A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects – and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.

Cholesterol :: Corazonas Foods & Brandeis University partner to create cholesterol reducing snacks

Corazonas Foods, Inc., creators of great-tasting, heart-healthy snack foods, has announced an exclusive licensing agreement with Brandeis University to utilize its technology in creating several new categories of heart-healthy snacks. Brandeis’s innovative technology allows high levels of plant sterols to be incorporated into snack foods while retaining the product’s outstanding flavor.

Folic Acid :: Folic acid lowers blood arsenic levels

A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water. This toxic element, naturally present in some aquifers used for drinking, is currently a significant public health problem in at least 70 countries, including several developing countries and also parts of the U.S.

Hunter Syndrome :: Shire’s ELAPRASE approved in Japan for treatment of Hunter Syndrome

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that Japan’s Ministry of Health, Labour and Welfare has approved ELAPRASE, a human enzyme replacement therapy for the treatment of Hunter syndrome, for sale and marketing in Japan. Since its U.S. approval in July 2006, ELAPRASE is now approved for marketing and commercial distribution in 34 countries worldwide.

Diabetes :: New IDF guidelines raise importance of post-meal glucose control

The International Diabetes Federation (IDF) has published new guidelines on the contribution and impact of post-meal glucose in diabetes disease management at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) on September_19, 2007. The IDF recognises the growing evidence that post-meal glucose is a key contributor to overall glycaemic control – particularly with respect to HbA1C levels, and that reducing post-meal glucose has a significant impact on the risk of developing diabetic complications.

AHF’s Innovative – Stay Negative – HIV Prevention Campaign

A post-campaign survey of AIDS Healthcare Foundation’s (AHF) innovative “Stay Negative” social marketing campaign recently revealed the initiative’s success at breaking through to its target audience and reaching its objective to create an effective health education and risk reduction campaign to raise awareness among gay males in Los Angeles County that HIV infection is still a serious threat.

Kidney :: Double cardiovascular benefit for people with chronic kidney disease

New research, published today in the Journal of American Society of Nephrology by the George Institute for International Health in Sydney, has found that lowering blood pressure protects stroke victims with chronic kidney disease from further strokes or heart attacks. Given the high risk of cardiovascular complications in people with chronic kidney disease, these results have significant implications for millions of people across the world.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack